Organogenesis Holdings Correlations
ORGO Stock | USD 3.34 0.01 0.30% |
A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Organogenesis Holdings moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Organogenesis Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Organogenesis Holdings Correlation With Market
Average diversification
The correlation between Organogenesis Holdings and DJI is 0.13 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Organogenesis Holdings and DJI in the same portfolio, assuming nothing else is changed.
Organogenesis |
Moving together with Organogenesis Stock
Moving against Organogenesis Stock
0.64 | PFE | Pfizer Inc Earnings Call Next Week | PairCorr |
0.5 | AZN | AstraZeneca PLC ADR | PairCorr |
0.43 | SNY | Sanofi ADR | PairCorr |
0.39 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.32 | GSK | GlaxoSmithKline PLC ADR Sell-off Trend | PairCorr |
0.53 | BA | Boeing Fiscal Year End 29th of January 2025 | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Organogenesis Stock performing well and Organogenesis Holdings Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Organogenesis Holdings' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
SHPH | 4.58 | (0.63) | 0.00 | (18.35) | 0.00 | 11.48 | 50.96 | |||
MNK | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
LSDI | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
ALIM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
LFCR | 3.32 | 0.45 | 0.08 | (2.59) | 4.86 | 8.11 | 28.39 | |||
RDHL | 3.18 | (0.55) | 0.00 | (1.46) | 0.00 | 5.91 | 27.36 | |||
TARO | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
COLL | 1.90 | (0.18) | 0.00 | (0.46) | 0.00 | 2.77 | 16.22 | |||
ADMP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
TKNO | 4.21 | 0.48 | 0.09 | 0.53 | 4.67 | 9.71 | 33.80 |
Organogenesis Holdings Corporate Management
BA Esq | VP Counsel | Profile | |
Patrick Bilbo | Chief Officer | Profile | |
Thomas Pearl | Vice Resources | Profile | |
Zorina Pitkin | VP Systems | Profile | |
Brian Grow | Chief Officer | Profile | |
Kurt Matheson | VP Marketing | Profile |